Created at Source Raw Value Validated value
Aug. 30, 2022, 9:30 p.m. usa

Part 1 and Part 2 : Number of participants with solicited local and systemic Adverse Events (AEs);Part 1 and Part 2 : Percentage of participants with all AEs;Part 1 and Part 2 : Percentage of participants with Medically Attended Adverse Events (MAAEs), Adverse Events of Special Interest (AESIs) and Serious Adverse Events (SAEs)

Part 1 and Part 2 : Number of participants with solicited local and systemic Adverse Events (AEs);Part 1 and Part 2 : Percentage of participants with all AEs;Part 1 and Part 2 : Percentage of participants with Medically Attended Adverse Events (MAAEs), Adverse Events of Special Interest (AESIs) and Serious Adverse Events (SAEs)